Financials
Financial year 2025
Qualico Pharma from Fernelmont, company number BE1015581981, closed financial year 2025 with a result of € 65,048 after tax. For that financial year Qualico Pharma recorded a gross margin of € 83,528 and equity of € 78,691. Compared with financial year 2024, the result moved from € 12,310 to € 65,048. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.
€ 78,691
▲ € 64,215 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 65,048
▲ € 52,738 vs 2024
Profit after tax over the fiscal year.
€ 85,356
▲ € 85,161 vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 833 paid out
1 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 2,080
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 8,830
▲ € 8,245 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 24,762
▲ € 19,106 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 17,318 | € 83,528 | ▲ € 66,210 |
| Profit after taxes | € 12,310 | € 65,048 | ▲ € 52,738 |
| Equity | € 14,477 | € 78,691 | ▲ € 64,215 |
| Total debts | € 7,398 | € 42,878 | ▲ € 35,480 |
| Cash | € 195 | € 85,356 | ▲ € 85,161 |
| Retained profit | € 11,477 | € 75,691 | ▲ € 64,215 |
| Dividend | € 833 | € 833 | |
| Balance sheet total | € 21,875 | € 121,569 | ▲ € 99,694 |
Key figures of Qualico Pharma, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Qualico Pharma?
What happened at Qualico Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 65,048 (▲ € 52,738 vs 2024). Source: NBB ↗
- New establishment in Fernelmont. KBO
- François Pimpurniaux became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 12,310 profit in 2024 to € 65,048 profit in 2025.
Paid € 21,443 in corporate taxes since 2024.
Best year ever: 2025, with € 65,048 profit.
Paid out € 1,666 in dividends to the owners in total.
A new publication or filing at Qualico Pharma? We notify you, reason included.
Follow Qualico PharmaDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Qualico Pharma is François Pimpurniaux.
Directors
According to the 2025 annual accounts
François Pimpurniaux
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Rue Général-Piron, Nov. 1
5380 Fernelmont
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1015.581.981
- VAT number
- BE 1015.581.981
- Registered office
- Rue Général-Piron, Nov. 1, 5380 Fernelmont
- Names & denominations
- Qualico Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 October 2024
- Peppol
- Active · Active since 9 Dec 2025
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering